TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014
TCL Archive Carcinogenesis Testing Moved Out of DCCP To New Status As Division, Giving Rall More Authority September 14, 1979
TCL Archive Also in this 8-page Issue: Safety Warnings Are Added to Labels for Epo and Avastin. January 21, 2005
TCL Archive Sen. Specter Seeks NCI Explanation of Delay in P-4 Breast Cancer Prevention Trial. May 25, 2007